Relmada Therapeutics Presents Positive Initial Phase 2 NDV-01 Data at AUA2025

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/1/2026

1. AMZN
2. RBLX
3. AAPL
4. COIN
5. RDDT
6. NBIX
7. DXCM
8. FND
9. GH
10. GDDY

Go back to Relmada Therapeutics Presents Positive Initial Phase 2 NDV-01 Data at AUA2025
(NASDAQ: RLMD) Delayed: 5.31 -0.04 (0.75%)
Previous Close $5.35    52 Week High $4.10 
Open $5.38    52 Week Low $0.87 
Day High $5.40    P/E N/A 
Day Low $5.00    EPS $0.00 
Volume 1,717,952